Literature DB >> 3028595

Pathology of nasopharyngeal carcinoma. Proposal of a new histologic classification correlated with prognosis.

H C Hsu, C L Chen, M M Hsu, T C Lynn, S M Tu, S C Huang.   

Abstract

To establish a new histologic classification with better correlation with patient prognosis, the histologic features of nasopharyngeal carcinoma (NPC) were correlated with prognosis and clinical stage among 494 patients who had been followed a minimum of 5 years after initial radiotherapy. A slight modification of World Health Organization (WHO) classification by the separation of spindle cell variant from the nonkeratinizing (NK) and undifferentiated carcinomas (UD) provided a better prognostic correlation: keratinizing squamous cell carcinoma (KS), spindle cell carcinoma (SP), round cell carcinoma (RC), and mixed cell carcinoma (Mix, or NK); 5-year survival rates were 21%, 41%, 51.8%, and 54%, respectively. This prognostic distinction was further improved by dividing the three nonkeratinizing carcinomas (SP, RC, and Mix) into two subtypes each, according to the degree of cell anaplasia and pleomorphism: Type A (with marked anaplasia and/or pleomorphism), and Type B (with moderate or little anaplasia). The three Type A carcinomas had very similar 5-year survival rates (33.3 to 38.6%), as did the three Type B carcinomas (60% to 71.8%). Therefore, a working formulation for the malignancy of NPC emerged: high-grade malignancy (KS; 5-year survival, 21%), intermediate malignancy (Type A carcinomas, 5-year survival, 30%-40%), and low-grade malignancy (Type B carcinomas, 5-year survival rate, 60%-72%). The prognostic distinction remained true after stratification by clinical stage. Therefore, the histologic condition of the tumor of NPC correlated with patient's prognosis.

Entities:  

Mesh:

Year:  1987        PMID: 3028595     DOI: 10.1002/1097-0142(19870301)59:5<945::aid-cncr2820590516>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Quantity of nuclear DNA in malignancies and benign lymphadenopathies associated with Epstein-Barr virus.

Authors:  T Lehtinen; M Lehtinen; R Aine; K Dammert; P Kulomaa; M Alavaikko; P Leinikki
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

2.  Prognostic analysis of patients with locally advanced nasopharyngeal carcinoma following intensity modulated radiation therapy.

Authors:  Yajie Zhao; Lin Shen; Xinqiong Huang; Yuxiang He; Jun Fu; Yujie Qian; Shan Li; Na Zhao; Liangfang Shen
Journal:  Oncol Lett       Date:  2018-01-24       Impact factor: 2.967

Review 3.  The nature of the head and neck cancer.

Authors:  A G Maran; J A Wilson; M N Gaze
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

4.  High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance.

Authors:  Laura Caggiari; Massimo Guidoboni; Emanuela Vaccher; Luigi Barzan; Giovanni Franchin; Annunziata Gloghini; Debora Martorelli; Paola Zancai; Maria Teresa Bortolin; Mario Mazzucato; Diego Serraino; Antonino Carbone; Paolo De Paoli; Riccardo Dolcetti
Journal:  Infect Agent Cancer       Date:  2007-03-01       Impact factor: 2.965

5.  Argyrophilic nucleolar organiser region counts and prognosis in pharyngeal carcinoma.

Authors:  A Pich; P Pisani; M Kzengli; N Cappello; R Navone
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

6.  Patterns of Care and Outcome Analysis of Nasopharyngeal Carcinoma: An Indonesian Single Institution Study.

Authors:  Hamida Hayati Faisal; Nobuteru Kubo; Endang Nuryadi; Joedo Prihartono; Tubagus Djumhana Atmakusuma; Lisnawati Rachmadi; Takahiro Oike; Takashi Nakano; Soehartati A Gondhowiardjo; Marlinda Adham
Journal:  Asian Pac J Cancer Prev       Date:  2020-05-01

7.  A new prognostic histopathologic classification of nasopharyngeal carcinoma.

Authors:  Hai-Yun Wang; Yih-Leong Chang; Ka-Fai To; Jacqueline S G Hwang; Hai-Qiang Mai; Yan-Fen Feng; Ellen T Chang; Chen-Ping Wang; Michael Koon Ming Kam; Shie-Lee Cheah; Ming Lee; Li Gao; Hui-Zhong Zhang; Jie-Hua He; Hao Jiang; Pei-Qing Ma; Xiao-Dong Zhu; Liang Zeng; Chun-Yan Chen; Gang Chen; Ma-Yan Huang; Sha Fu; Qiong Shao; An-Jia Han; Hai-Gang Li; Chun-Kui Shao; Pei-Yu Huang; Chao-Nan Qian; Tai-Xiang Lu; Jin-Tian Li; Weimin Ye; Ingemar Ernberg; Ho Keung Ng; Joseph T S Wee; Yi-Xin Zeng; Hans-Olov Adami; Anthony T C Chan; Jian-Yong Shao
Journal:  Chin J Cancer       Date:  2016-05-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.